###begin article-title 0
Genome-Wide Association Scan Meta-Analysis Identifies Three Loci Influencing Adiposity and Fat Distribution
###end article-title 0
###begin p 1
###xml 1451 1456 <span type="species:ncbi:8895">Swift</span>
###xml 1971 1976 <span type="species:ncbi:8895">Swift</span>
Conceived and designed the experiments: C. Lindgren, I. Heid, J. Randall., C. Lamina, V. Steinthorsdottir, L. Peltonen, I. Barroso, M. McCarthy. Performed the experiments: J. Zhao, A. Bennett, G. Crawford, A. Dominiczak, C. Groves, C. Guiducci, F. Payne, J. Peden, L. Scott, K. Silander, H. Stringham, T. Tuomi, M. Uda, P. Vollenweider, G. Waeber, J. Witteman. Analyzed the data: C. Lindgren, I. Heid, J. Randall., C. Lamina, V. Steinthorsdottir., L. Qi, E. Speliotes, G. Thorleifsson, C. Willer, B. Herrera, A. Jackson, N. Lim, P. Scheet, N. Soranzo, N. Amin, Y. Aulchenko, J. Chambers, A. Drong, J. Luan, H. Lyon, F. Rivadeneira, S. Sanna, N. Timpson, M. Zillikens, P. Almgren, S. Bandinelli, A. Bennett, R. Bergman, L. Bonnycastle, S. Bumpstead, S. Chanock, L. Cherkas, P. Chines, L. Coin, C. Cooper, G. Crawford, A. Doering, A. Dominiczak, A. Doney, S. Ebrahim, P. Elliott, M. Erdos, K. Estrada, L. Ferrucci, G. Fischer, N. Forouhi, C. Gieger, H. Grallert, C. Groves, S. Grundy, C. Guiducci, D. Hadley, A. Hamsten, A. Havulinna, A. Hofman, R. Holle, J. Holloway, T. Illig, B. Isomaa, L. Jacobs, K. Jameson, P. Jousilahti, J. Kuusisto, J. Laitinen, G. Lathrop, D. Lawlor, M. Mangino, W. McArdle, T. Meitinger, M. Morken, A. Morris, P. Munroe, N. Narisu, Anna Nordstrom, P. Nordstrom, B. Oostra, C. Palmer, F. Payne, J. Peden, I. Prokopenko, F. Renstrom, A. Ruokonen, M. Sandhu, L. Scott, A. Scuteri, K. Silander, K. Song, X. Yuan, H. Stringham, A. Swift, C. Wallace, G. Walters, M. Weedon, C. Zhang, W. Zhang, A. Kong, D. Strachan, T. Tanaka, C. Van Duijn, D. Waterworth, T. Frayling, R. Loos. Contributed reagents/materials/analysis tools: S. Chanock, L. Cherkas, P. Chines, C. Cooper, A. Doering, A. Doney, S. Ebrahim, A. Hamsten, B. Isomaa, P. Jousilahti, F. Karpe, J. Kuusisto, J. Laitinen, G. Lathrop, D. Lawlor, T. Meitinger, A. Morris, P. Munroe, A. Nordstrom, P. Nordstrom, B. Oostra, C. Palmer, F. Renstrom, A. Ruokonen, V. Salomaa, M. Sandhu, A. Scuteri, A. Swift, T. Tuomi, M. Uda, P. Vollenweider, G. Waeber, J. Witteman, M. Caulfield, F. Collins, G. Davey Smith, I. Day, P. Franks, A. Hattersley, F. Hu, M-R. Jarvelin, A. Kong, J. Kooner, M. Laakso, E. Lakatta, V. Mooser, A. Morris, L. Peltonen, N. Samani, T. Spector, D. Strachan, T. Tanaka, J. Tuomilehto, A. Uitterlinden, C. Van Duijn, N. Wareham, H. Watkins, D. Waterworth, M. Boehnke, P. Deloukas, L. Groop, D. Hunter, U.Thorsteinsdottir, D. Schlessinger, H. Wichmann, T. Frayling, G. Abecasis, J. Hirschhorn, R. Loos, K. Mohlke, I. Barroso, M. McCarthy. Wrote the paper: C. Lindgren, I. Heid, J. Randall., C. Lamina, V. Steinthorsdottir., L. Qi, E. Speliotes, G. Thorleifsson, C. Willer, C. Van Duijn, M. Boehnke, U.Thorsteinsdottir, G. Abecasis, J. Hirschhorn, R. Loos, K. Stefansson, K. Mohlke, I. Barroso, M. McCarthy. Directed the project: G. Abecasis, J. Hirschhorn, R. Loos, K. Stefansson, K. Mohlke, I. Barroso, M. McCarthy.
###end p 1
###begin p 2
###xml 53 60 40 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s011">Text S1</xref>
paragraph sign A full list of members is provided in Text S1.
###end p 2
###begin article-title 3
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NRXN3</italic>
NRXN3 is a Novel Locus for Waist Circumference: A Genome-Wide Association Study from the CHARGE Consortium
###end article-title 3
###begin p 4
###xml 576 582 576 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 588 589 588 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 598 601 598 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;11</sup>
###xml 607 611 607 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MSRA</italic>
###xml 617 618 617 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 627 629 627 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 652 659 652 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LYPLAL1</italic>
###xml 700 701 700 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 710 712 710 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 733 739 733 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 833 840 833 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LYPLAL1</italic>
###xml 688 693 <span type="species:ncbi:9606">women</span>
###xml 1048 1053 <span type="species:ncbi:9606">human</span>
To identify genetic loci influencing central obesity and fat distribution, we performed a meta-analysis of 16 genome-wide association studies (GWAS, N = 38,580) informative for adult waist circumference (WC) and waist-hip ratio (WHR). We selected 26 SNPs for follow-up, for which the evidence of association with measures of central adiposity (WC and/or WHR) was strong and disproportionate to that for overall adiposity or height. Follow-up studies in a maximum of 70,689 individuals identified two loci strongly associated with measures of central adiposity; these map near TFAP2B (WC, P = 1.9x10-11) and MSRA (WC, P = 8.9x10-9). A third locus, near LYPLAL1, was associated with WHR in women only (P = 2.6x10-8). The variants near TFAP2B appear to influence central adiposity through an effect on overall obesity/fat-mass, whereas LYPLAL1 displays a strong female-only association with fat distribution. By focusing on anthropometric measures of central obesity and fat distribution, we have identified three loci implicated in the regulation of human adiposity.
###end p 4
###begin title 5
Author Summary
###end title 5
###begin p 6
###xml 605 611 605 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 616 620 616 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MSRA</italic>
###xml 668 675 668 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LYPLAL1</italic>
###xml 855 862 855 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LYPLAL1</italic>
###xml 1001 1006 <span type="species:ncbi:9606">human</span>
Here, we describe a meta-analysis of genome-wide association data from 38,580 individuals, followed by large-scale replication (in up to 70,689 individuals) designed to uncover variants influencing anthropometric measures of central obesity and fat distribution, namely waist circumference (WC) and waist-hip ratio (WHR). This work complements parallel efforts that have been successful in defining variants impacting overall adiposity and focuses on the visceral fat accumulation which has particularly strong relationships to metabolic and cardiovascular disease. Our analyses have identified two loci (TFAP2B and MSRA) associated with WC, and a further locus, near LYPLAL1, which shows gender-specific relationships with WHR (all to levels of genome-wide significance). These loci vary in the strength of their associations with overall adiposity, and LYPLAL1 in particular appears to have a specific effect on patterns of fat distribution. All in all, these three loci provide novel insights into human physiology and the development of obesity.
###end p 6
###begin title 7
Introduction
###end title 7
###begin p 8
###xml 220 223 220 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Pischon1">[1]</xref>
###xml 456 459 456 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Yusuf1">[2]</xref>
###xml 460 463 460 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Baik1">[3]</xref>
The accumulation of abnormal amounts of intra-abdominal fat (central adiposity) is associated with serious adverse metabolic and cardiovascular outcomes, including type 2 diabetes (T2D) and atherosclerotic heart disease [1]. Indeed, because the medical consequences of increasing fat mass are disproportionately attributable to the extent of central adiposity, measures of overall adiposity, such as body mass index (BMI), fail to capture all of this risk [2],[3].
###end p 8
###begin p 9
###xml 74 75 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 171 179 147 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s001">Table S1</xref>
###xml 291 292 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 332 335 296 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Kamel1">[4]</xref>
###xml 647 650 611 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Schousboe1">[5]</xref>
###xml 772 775 712 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Rose1">[6]</xref>
###xml 903 906 843 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Zillikens1">[7]</xref>
###xml 1100 1103 1040 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Garg1">[8]</xref>
###xml 283 288 <span type="species:ncbi:9606">women</span>
Measures of central and overall adiposity are highly correlated (BMI has r2approximately0.9 with waist circumference [WC] and approximately0.6 with waist-hip ratio [WHR], Table S1). WC and WHR are correlated with more precise measures of intra-abdominal fat measured by MRI in obese women (r2approximately0.6 and 0.5, respectively) [4]. Several lines of evidence indicate that individual variability in patterns of fat distribution involves local, depot-specific processes, which are independent of the predominantly neuronal mechanisms that control overall energy balance. First, anthropometric measures of central adiposity are highly heritable [5] and, after correcting for BMI, heritability estimates remain high (approximately60% for WC and approximately45% for WHR) [6]. Second, there are substantial gender-specific differences in fat distribution, and these appear to reflect genetic influences [7]. Third, uncommon monogenic syndromes (the partial lipodystrophies) demonstrate that DNA variants can have dramatic effects on the development and/or maintenance of specific regional fat-depots [8].
###end p 9
###begin p 10
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Dina1">[9]</xref>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Thorleifsson1">[17]</xref>
Efforts to identify common and rare variants influencing BMI and risk of obesity have emphasized the key role of neuronal (hypothalamic) regulation of overall adiposity [9]-[17] but provided few clues to processes that are specifically responsible for individual variation in central obesity and fat distribution. Definition of the mechanisms involved in the regulation of fat distribution in general, and visceral fat mass in particular, is therefore key to understanding obesity and its accompanying morbidity and mortality. Given the challenges associated with the pharmacological manipulation of hypothalamic processes, the identification of pathways influencing abdominal fat accumulation would also present novel opportunities for therapeutic development.
###end p 10
###begin p 11
With this in mind, we set out to identify genetic loci influencing anthropometric measures of central obesity and fat distribution, namely, WC and WHR. Our meta-analysis of 16 genome wide association studies (GWAS), followed by large-scale replication testing, generating a combined sample of up to 118,691 individuals of European origin, has identified three loci associated with these critical biomedical traits.
###end p 11
###begin title 12
Results/Discussion
###end title 12
###begin p 13
###xml 92 100 92 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000508-g001">Figure 1</xref>
###xml 252 260 252 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s002">Table S2</xref>
Our strategy for identifying common variants influencing central adiposity is summarized in Figure 1. The study was based on an initial ("stage 1") meta-analysis of GWAS data to identify SNPs strongly-associated with measures of central adiposity (see Table S2). We then focused our "stage 2" follow-up efforts on the subset of those signals for which the strength of the evidence of association for measures of central adiposity (WC and WHR) appeared to be substantially stronger than that observed for overall adiposity and/or height. We reasoned that this subset of signals would be enriched for variants with preferential influences on central fat accumulation.
###end p 13
###begin title 14
Project outline.
###end title 14
###begin p 15
###xml 206 214 206 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s002">Table S2</xref>
###xml 263 265 261 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 307 309 305 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 355 356 353 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 457 466 455 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s010">Table S10</xref>
###xml 468 472 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Frayling1">[10]</xref>
###xml 474 478 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Loos1">[14]</xref>
###xml 480 484 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Willer1">[16]</xref>
###xml 485 489 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Thorleifsson1">[17]</xref>
We started out with a meta-analysis of GWAS data from 16 cohorts comprising 38,580 individuals informative for WC and 37,670 for WHR. We selected 23 SNPs of our top signals based on the following criteria (Table S2): preliminary stage 1 meta-analysis P-value</=10-5, BMI P-value>0.01 and height P-value>5x10-3. We supplemented these 23 independent loci (r2<0.2) SNPs with three additional candidate signals. Further, we excluded recently reported BMI loci (Table S10) [10], [14], [16]-[17]. These 26 SNPs were followed up in our stage 2 samples (N = maximum of 70,689 individuals). Further, we sought to confirm WC signals reaching genome wide significance in the combined analysis of stage 1 and 2 data in GWA data from the CHARGE consortium (for which WHR was not available). The data from the Rotterdam and ERF cohorts (up to 6,702 individuals) which were included in both CHARGE and stage 2 data, were counted only once in the overall analysis.
###end p 15
###begin title 16
GWAS Meta-Analysis for Anthropometric Measures of Central Obesity
###end title 16
###begin p 17
###xml 141 149 141 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s003">Table S3</xref>
###xml 290 298 290 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s004">Table S4</xref>
###xml 435 443 435 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s005">Table S5</xref>
###xml 1053 1060 1050 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Methods</xref>
The stage 1 meta-analysis combined data from 16 GWAS scans (N = 38,580, all of European ancestry) informative for anthropometric phenotypes (Table S3). We selected two complementary but related measures of central adiposity for analysis: waist circumference (WC) and waist-hip ratio (WHR) (Table S4). In total, 2,573,738 directly typed or imputed SNPs were tested for association using regression analysis under an additive model (see Table S5 for details). We conducted a weighted Z-score meta-analysis combining gender- and sample-specific association P-values gathered from each contributing study. We also performed an inverse-variance meta-analysis using regression results (beta-estimates and standard errors) after applying uniform analysis procedures across all contributing samples. The results of the two meta-analyses were highly-congruent. Here, we report association P-values based on the former, as it was the first-completed and was used to select SNPs for follow-up genotyping. Reported effect-size estimates derive from the latter (see Methods for further details).
###end p 17
###begin p 18
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Devlin1">[18]</xref>
###xml 215 217 210 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC</sub>
###xml 259 264 249 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC_WC</sub>
###xml 279 289 264 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC_WC_1000</sub>
###xml 349 355 329 335 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC_WHR</sub>
###xml 370 380 345 355 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC_WC_1000</sub>
###xml 395 402 370 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s011">Text S1</xref>
###xml 404 408 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-deBakker1">[19]</xref>
###xml 557 559 532 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 668 676 643 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000508-g002">Figure 2</xref>
###xml 869 872 844 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 899 902 874 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;20</sup>
###xml 908 912 883 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MC4R</italic>
###xml 940 943 915 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;11</sup>
###xml 988 989 963 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1075 1084 1050 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s010">Table S10</xref>
###xml 1086 1089 1061 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Dina1">[9]</xref>
###xml 1090 1094 1065 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Frayling1">[10]</xref>
###xml 1096 1100 1071 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Scuteri1">[12]</xref>
###xml 1101 1105 1076 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Loos1">[14]</xref>
###xml 1107 1111 1082 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Willer1">[16]</xref>
###xml 1112 1116 1087 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Thorleifsson1">[17]</xref>
###xml 1117 1121 1092 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Meyre1">[20]</xref>
The individual studies as well as the results from the overall meta-analysis were corrected for residual inflation of the test statistic using genomic control methods [18]. The overall genomic control lambda (lambdaGC) in the mixed-gender analysis were lambdaGC_WC = 1.09 (lambdaGC_WC_1000 = 1.003 [standardised to a sample size of 1000]) and lambdaGC_WHR = 1.07 (lambdaGC_WC_1000 = 1.002) (see Text S1) [19]. From these data, we identified a set of 76 SNPs (one per independent region of association, based on an arbitrary follow-up P-value threshold of 10-5 in preliminary pre-GC corrected analyses) that showed evidence of association to one or both of the traits (Figure 2). As might have been expected given the strong correlations between measures of central adiposity and BMI, the most significant associations for WC and WHR were observed for SNPs mapping near FTO (rs1421085, WC, P = 3.7x10-20) and MC4R (rs17700144, WC, P = 6.2x10-11). These two markers are highly correlated (r2>0.8) with markers that represent two of the strongest signals for overall adiposity (Table S10) [9]-[10], [12]-[14], [16]-[17],[20].
###end p 18
###begin title 19
Genome-wide association results for GIANT (Stage 1).
###end title 19
###begin p 20
###xml 401 405 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Frayling1">[10]</xref>
###xml 406 410 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Loos1">[14]</xref>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Willer1">[16]</xref>
###xml 755 759 755 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Frayling1">[10]</xref>
###xml 761 765 761 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Loos1">[14]</xref>
###xml 767 771 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Willer1">[16]</xref>
###xml 772 776 772 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Thorleifsson1">[17]</xref>
###xml 933 937 933 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Frayling1">[10]</xref>
###xml 939 943 939 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Loos1">[14]</xref>
###xml 945 949 945 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Willer1">[16]</xref>
###xml 950 954 950 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Thorleifsson1">[17]</xref>
A. Manhattan plots showing significance of association of all SNPs in the Stage 1 GIANT meta-analysis with central obesity phenotypes. SNPs are plotted on the x-axis according to their position on each chromosome against association with central obesity measure (WC or WHR) on the y-axis (shown as -log10 P-value). SNPs that have been previously reported to show association with BMI is shown in blue [10],[14],[16] and the two regions showing strong associations in the overall, non-gender-stratified analyses are shown in green. Other SNPs taken forward into stage 2 follow-up are indicated in red. B. Quantile-quantile (QQ) plots of SNPs; after Stage 1 GIANT meta-analysis (black) and after removing any SNPs surrounding the recently reported BMI loci [10], [14], [16]-[17] (blue). The grey areas in the QQ plots represent the 95% confidence intervals around the test statistics and after excluding the recently reported BMI loci [10], [14], [16]-[17], there is no indication of excess of signal.
###end p 20
###begin title 21
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Silico</italic>
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">De Novo</italic>
In Silico and De Novo Follow-Up
###end title 21
###begin p 22
###xml 354 356 352 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 549 557 545 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s002">Table S2</xref>
###xml 705 713 701 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s002">Table S2</xref>
###xml 794 796 790 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
From this initial set of 76 WC- and/or WHR- associated signals, we sought to enrich for variants with specific impacts on central adiposity, by identifying a subset of 23 SNPs for which there was greatest evidence for a disproportionate effect on central adiposity, as opposed to overall adiposity or height. These 23 variants all had strong (i.e. P</=10-5) associations with WC and/or WHR while displaying only weak evidence of an association with overall adiposity (BMI, P>0.01) or adult height (P>/=0.005) in the stage 1 GWAS meta-analysis data (Table S2). We also included three variants for reasons of biological candidacy, even though they did not precisely meet all P-value threshold criteria (see Table S2). Given the stage 1 sample size of 38,580, the follow-up P-value threshold of 10-5 provides 80% power to detect a per-allele beta of 0.045 (equivalent, for example, to a per-allele effect on WC of approximately 0.5 cm), given an additive model and MAF of 20%.
###end p 22
###begin p 23
###xml 31 40 31 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 175 182 175 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 288 296 288 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s003">Table S3</xref>
###xml 474 483 474 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s002">Tables S2</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s006">S6</xref>
For these 26 SNPs, we obtained in silico follow-up data from another 8 studies with GWAS data (Stage 2a: maximum N = 13,830 individuals, all European-ancestry), and performed de novo genotyping in subjects from 20 additional studies (Stage 2b: maximum N = 56,859, all European-ancestry) (Table S3). Follow-up analyses were restricted to the precise phenotype(s) (WC and/or WHR) for which the SNP had been selected in stage 1 making a total of 30 SNP-phenotype combinations (Tables S2 and S6).
###end p 23
###begin p 24
###xml 117 126 117 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s002">Tables S2</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s003">S3</xref>
###xml 265 267 265 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 269 276 269 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000508-t001">Table 1</xref>
###xml 278 286 278 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000508-g003">Figure 3</xref>
###xml 399 401 399 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 413 419 413 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 552 554 552 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MSRA</italic>
###xml 676 678 676 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 702 706 702 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TBCE</italic>
After combining gender- and study-specific measures of association across all studies (maximum possible N = 109,269: Tables S2 and S3), we identified three signals reaching genome-wide levels of significance in the joint analysis of stage 1 and stage 2 data (P<5x10-8, Table 1, Figure 3). In all three instances, the association was observed with WC. The first (rs987237, chromosome 6p12: P = 4.5x10-9) maps near TFAP2B, which encodes transcription factor activating enhancer-binding protein 2 beta. The second (rs7826222, chromosome 8p23.1: P = 1.2x10-8) resides near MSRA, encoding methionine sulfoxide reductase A, whilst the third (rs6429082, chromosome 1q42.3: P = 2.6x10-8) is located within the TBCE (tubulin folding cofactor E) gene region.
###end p 24
###begin title 25
Regional plots of loci highlighted in this study.
###end title 25
###begin p 26
###xml 425 432 425 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000508-t001">Table 1</xref>
###xml 705 706 705 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 967 968 967 968 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 217 222 <span type="species:ncbi:9606">women</span>
SNPs are plotted by position on chromosome against association (-log10 p-value) with central obesity phenotype (WC or WHR) using stage 1 (GWAS meta-analysis) data. In the case of panel (b), analyses are restricted to women only. In each panel, the SNP with the strongest association based on stage 1 data is denoted with a purple diamond: the P-value attached represents the final P-value attained across all available data (Table 1). Estimated recombination rates (from HapMap-CEU) are plotted in purple to reflect the local LD structure on a secondary Y-axis. The SNPs surrounding the most significant SNP (purple diamond) are color-coded (see inset) to reflect their LD with this SNP (using pair-wise r2 values from HapMap CEU). Genes and the position of exons, as well as the direction of transcription, are shown below the plots (using data from the UCSC genome browser, genome.ucsc.edu). The grey area marks the extent of the region that includes any SNP with r2>/=0.3 relative to the SNP with the strongest stage 1 association signal. Hash marks represent SNP positions on each genotyping array used by any individual study and also show SNP positions after imputation.
###end p 26
###begin title 27
SNPs with genome-wide significant evidence for association with central adiposity and fat distribution.
###end title 27
###begin p 28
Alleles: the first allele listed in the parenthesis is the effect allele, for which the allele frequency is given.
###end p 28
###begin p 29
Stage 1: data from stage 1 GIANT GWAS meta-analysis.
###end p 29
###begin p 30
###xml 37 46 37 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
Stage 2a: data from meta-analysis of in silico studies.
###end p 30
###begin p 31
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
Stage 2b: data from meta-analysis of de novo genotyped studies.
###end p 31
###begin p 32
###xml 49 58 49 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 82 89 82 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
Stage 1+2: data from stage 1 GIANT analyzed with in silico studies (Stage 2a) and de novo genotyped studies (Stage 2b).
###end p 32
###begin p 33
Overall: data from meta-analysis of Stage1, 2a, 2b and CHARGE.
###end p 33
###begin p 34
Total sample sizes do not always reflect the sum of component studies due to (a) rounding errors in non-integeric sample sizes arising from the weighting procedure; (b) overlap, for some markers, of data from the Rotterdam and ERF cohorts (up to 6,702 individuals) which were included in both CHARGE and stage 2 data, but which are counted only once in the overall analysis.
###end p 34
###begin p 35
P-values: all P-values we report here are two-sided.
###end p 35
###begin p 36
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MRSA</italic>
###xml 8 12 <span type="species:ncbi:1280">MRSA</span>
For the MRSA locus, genotypes for rs7826222 were only available for a subset of the CHARGE samples (N = 8,097). This is likely due to the fact that this SNP has been renamed to rs545854 in NCBI build 36 and was consequently one of the SNPs omitted from HapMap release 22 and therefore is not present in build 36 imputations based on that release of HapMap.
###end p 36
###begin p 37
###xml 152 159 152 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Methods</xref>
- Data not available. Effect size estimates and overall WHR results are not available as CHARGE only analysed WC using the weighted Z-score method (see Methods).
###end p 37
###begin title 38
Confirmation in CHARGE Consortium GWAS Data
###end title 38
###begin p 39
As a final stage of confirmation, we analysed genotype data for rs987237, rs7826222 and rs6429082 made available to us by the CHARGE consortium, whose members had recently completed a GWAS meta-analysis of WC in 31,375 individuals (of which up to 6,702 individuals were overlapping with samples from our stage 2 and were removed before the joint meta-analysis).
###end p 39
###begin p 40
###xml 3 9 3 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 114 116 114 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 159 162 159 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;11</sup>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MSRA</italic>
###xml 345 352 345 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s011">Text S1</xref>
###xml 545 547 545 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 550 557 550 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000508-t001">Table 1</xref>
At TFAP2B, CHARGE analyses revealed directionally-consistent association with WC (rs987237, N = 31,372, P = 3.6x10-4) resulting in a combined P-value of 1.9x10-11 (N = 118,691). At MSRA, genotypes for rs7826222 could only be imputed in a subset (N = 8,097) of CHARGE samples (this reflects SNP nomenclature issues rather than data quality - see Text S1). Nonetheless, the effect in CHARGE was directionally consistent (P = 0.28), and in the overall results (N = 80,210) for this SNP, the evidence for association with WC was improved (P = 8.9x10-9) (Table 1).
###end p 40
###begin p 41
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TBCE</italic>
###xml 219 221 219 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 305 311 305 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 316 320 316 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MRSA</italic>
###xml 536 544 536 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s002">Table S2</xref>
###xml 316 320 <span type="species:ncbi:1280">MRSA</span>
In contrast, rs6429082 in TBCE showed no evidence of association with WC in the full CHARGE data set (N = 31,373, P = 0.12). Since analysis of the combined data set no longer reached genome-wide significance (P = 2.9x10-7), further studies will be required to establish the status of this signal. For the TFAP2B and MRSA loci, there was no evidence of heterogeneity of effect size across the various sample sets, and no evidence that the inclusion of diabetes or coronary artery disease case samples had any impact on the associations (Table S2).
###end p 41
###begin title 42
Gender-Specific Association Analyses
###end title 42
###begin p 43
###xml 136 139 136 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Zillikens1">[7]</xref>
###xml 368 375 368 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ZC3H11B</italic>
###xml 392 399 392 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LYPLAL1</italic>
###xml 554 556 554 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 559 567 559 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s002">Table S2</xref>
###xml 670 672 670 672 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 799 801 799 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 804 811 804 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000508-t001">Table 1</xref>
###xml 883 885 883 885 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 971 978 971 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LYPLAL1</italic>
Given the clear gender dimorphism of central obesity, and evidence that some genetic effects on fat distribution may be gender-specific [7], we reanalysed the stage 1 GWAS data, looking for effects restricted to males or females only. These analyses revealed a further locus of interest. SNPs, including rs2605100, within a gene desert on chromosome 1q41 (138 kb from ZC3H11B and 259 kb from LYPLAL1, encoding lysophospholipase-like protein 1) had shown modest evidence for association with WHR in our primary (both genders included) analysis (P = 3.6x10-6) (Table S2). However, in gender-specific analyses, this association was clearly restricted to females (P = 1.3x10-8; males: P = 0.50). When stage 1 and stage 2 data were combined, the female-only signal remained highly-significant (P = 2.6x10-8) (Table 1) with evidence of effect-size heterogeneity between genders (P = 1.1x10-3). As the CHARGE GWAS analyses were restricted to WC, we were unable to follow-up the LYPLAL1 signal in these data.
###end p 43
###begin title 44
Disentangling Effects on Overall and Central Adiposity
###end title 44
###begin p 45
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Frayling1">[10]</xref>
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Scuteri1">[12]</xref>
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Loos1">[14]</xref>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Willer1">[16]</xref>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Thorleifsson1">[17]</xref>
We had designed this study to be complementary to equivalent analyses of overall adiposity (as measured by BMI) conducted on many of the same samples [10], [12]-[14],[16],[17]. By focusing on widely-available anthropometric proxies of central adiposity, and targeting replication to those signals which, in the GWAS data, had the most compelling evidence for disproportionate effects on central adiposity, our aim had been to enrich for variants influencing regional rather than overall obesity, and thereby overcome the very strong correlations between these measures.
###end p 45
###begin p 46
###xml 124 130 124 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MSRA</italic>
###xml 141 148 141 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LYPLAL1</italic>
We were interested therefore in establishing the extent to which the confirmed, genome-wide associations identified at/near TFAP2B, MSRA and LYPLAL1 were indeed specific for central fat accumulation as opposed to being driven by other highly-correlated anthropometric traits (most notably overall adiposity as measured by BMI). To evaluate this, we used data from the stage 2 replication samples, from which we can expect to obtain less biased estimates of the relative effects across anthropometric phenotypes.
###end p 46
###begin p 47
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 244 247 244 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;12</sup>
###xml 387 393 387 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 668 676 668 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s007">Table S7</xref>
In the case of TFAP2B, these stage 2 data indicated that, notwithstanding the evidence for discordant effects in the stage 1 data (which led to its selection for follow up), rs987237 showed strong associations with overall adiposity (P = 7.0x10-12 for BMI in stage 2 alone). The association with WC remained only nominally significant in stage 2 (P = 0.02) after adjustment for BMI. The TFAP2B rs987237 G allele was weakly associated with overall fat mass (0.15% difference per-allele [P = 0.02] in 29,316 individuals with bioimpedance data; 0.25% difference per-allele [P = 0.02] in 13,039 additional individuals with dual energy X-ray absorptiometry (DXA) measures: Table S7). In the 7,346 individuals for which we had DXA information on fat distribution, there was no apparent association with percent central fat mass (P = 0.98), although this analysis is underpowered.
###end p 47
###begin p 48
###xml 167 173 167 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 230 236 230 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Maeda1">[21]</xref>
###xml 468 472 468 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Tao1">[22]</xref>
###xml 493 499 493 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 615 619 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Ikeda1">[23]</xref>
###xml 645 651 645 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 709 715 709 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 752 756 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Tsukada1">[24]</xref>
###xml 764 770 764 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 842 846 842 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Frayling1">[10]</xref>
###xml 847 851 847 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Loos1">[14]</xref>
###xml 852 856 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Willer1">[16]</xref>
###xml 857 861 857 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Thorleifsson1">[17]</xref>
###xml 1052 1056 1052 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Frayling1">[10]</xref>
###xml 1058 1062 1058 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Scuteri1">[12]</xref>
###xml 1063 1067 1063 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Loos1">[14]</xref>
###xml 1069 1073 1069 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Willer1">[16]</xref>
###xml 1074 1078 1074 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Thorleifsson1">[17]</xref>
###xml 1080 1086 1080 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
These data suggest that the chromosome 6p12 signal exerts its predominant effect on fat accumulation at multiple sites, a finding consistent with the known biology of TFAP2B, which is the most obvious candidate gene in the locus. TFAP2B encodes a transcription factor preferentially expressed in adipose tissue, and over-expression of the transcript in 3T3L1-adipocytes leads to insulin sensitivity via enhanced glucose transport and increased lipid accumulation [21],[22]. Over-expression of TFAP2B also down-regulates expression of the insulin-sensitizing hormone adiponectin by direct transcriptional repression [23]. Genetic variants within TFAP2B have recently been reported to correlate positively with TFAP2B transcript levels in adipose tissue [24]. Thus, TFAP2B can be added to the growing list of loci influencing overall adiposity [10],[14],[16],[17]. However, in contrast to most of the variants previously implicated in monogenic or multifactorial forms of obesity, which exert their effects on overall adiposity at the hypothalamic level [10], [12]-[14], [16]-[17], TFAP2B may be involved in global adipocyte response to positive energy balance.
###end p 48
###begin p 49
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LYPLAL1</italic>
###xml 149 151 149 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 315 317 315 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 498 500 498 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 656 663 656 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LYPLAL1</italic>
###xml 807 815 807 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s007">Table S7</xref>
###xml 1034 1041 1022 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LYPLAL1</italic>
###xml 1217 1221 1205 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Steinberg1">[25]</xref>
###xml 127 132 <span type="species:ncbi:9606">women</span>
###xml 293 298 <span type="species:ncbi:9606">women</span>
###xml 345 350 <span type="species:ncbi:9606">women</span>
In contrast, the signal on chromosome 1q41 (near LYPLAL1) showed relatively modest associations with overall obesity (stage 2, women only, P = 1.9x10-4 for BMI) and WC (P = 0.01). Crucially, the strength of the association with WHR was substantially greater after adjustment for BMI (stage 2, women only, P = 4.3x10-6). In the limited subset of women (N = 7,228) for whom direct measures of hip circumference (HC) could be retrieved, and in whom there was a proportionate signal for WHR (P = 5.2x10-4), we found no association with HC (P = 0.7) and a directionally consistent trend of association to WC (P = 0.06). Whilst these data would suggest that the LYPLAL1 signal does indeed have a specific effect on fat distribution, our own DXA data on regional fat distribution are non-contributory (N = 5,455) (Table S7), and large-scale clinical imaging studies will be required to explore this further. The obvious candidate within this locus (although it lies approximately259 kb downstream of the most strongly-associated variant) is LYPLAL1. This gene encodes a lysophospholipase-like 1 protein thought to act as a triglyceride lipase and reported to be up-regulated in subcutaneous adipose tissue of obese subjects [25].
###end p 49
###begin p 50
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MSRA</italic>
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MSRA</italic>
###xml 182 184 182 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MSRA</italic>
###xml 485 489 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNKS</italic>
###xml 714 718 714 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Yeh1">[26]</xref>
###xml 719 723 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Chi1">[27]</xref>
###xml 730 734 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TNKS</italic>
Biological connections between the MSRA locus and adiposity phenotypes are unclear at this stage. The signal near MSRA showed only weak association with overall adiposity (P = 2.2x10-3 for BMI in stage 2), but the strong association with WC in stage 2 samples became non-significant after BMI-adjustment (P = 0.11). The main proposed function of MSRA is to repair oxidative damage to proteins by enzymatic reduction of methionine sulfoxide. An alternative candidate in the vicinity is TNKS, which encodes a TRF1-interacting ankyrin-related ADP-ribose polymerase (tankyrase). Tankyrase is a peripheral membrane protein known to interact with insulin-responsive aminopeptidase (IRAP) in GLUT4 vesicles in adipocytes [26],[27]. Thus TNKS has a putative role in insulin-regulated glucose disposal into fat and other tissues.
###end p 50
###begin title 51
Variance Explained by the Associated Loci
###end title 51
###begin p 52
###xml 236 242 236 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MSRA</italic>
###xml 430 437 430 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LYPLAL1</italic>
###xml 488 493 <span type="species:ncbi:9606">women</span>
We estimated the variance in these traits attributable to the loci discovered using data from the KORA-S4 sample (the largest population-based sample within stage 2). The explained variance of WC was estimated to be 0.05% for rs987237 (TFAP2B) and 0.04% for rs7826222 (MSRA). This corresponds to absolute WC effect sizes of 0.49 and 0.43 cm respectively (as estimated across all population based samples in stage 2). The SNP near LYPLAL1 (rs2605100) explains 0.02% of the WHR variance in women (absolute effect size on WHR of 0.0014).
###end p 52
###begin title 53
Associations with Adverse Health Consequences
###end title 53
###begin p 54
###xml 263 270 263 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s011">Text S1</xref>
###xml 347 354 347 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LYPLAL1</italic>
###xml 403 405 403 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 407 415 407 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s008">Table S8</xref>
###xml 485 489 485 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Aulchenko1">[28]</xref>
###xml 658 662 658 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Kathiresan1">[29]</xref>
###xml 720 724 720 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Zeggini1">[30]</xref>
###xml 825 831 825 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 843 851 843 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s009">Table S9</xref>
###xml 894 900 894 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 967 971 967 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Maeda1">[21]</xref>
###xml 1105 1106 1105 1106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1150 1151 1150 1151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1307 1310 1307 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FTO</italic>
###xml 1469 1473 1469 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Freathy1">[31]</xref>
The accumulation of central adiposity has serious adverse health consequences including hyperlipidemia and increased risks of T2D. We examined the relationships between adiposity-related SNPs and these clinical phenotypes using available GWAS meta-analysis data (Text S1). We found an association between the WHR-increasing G-allele of rs2605100 (LYPLAL1) and increased fasting triglycerides (P = 3.9x10-4; Table S8) in data from a recent GWAS meta-analysis of 14,343 European samples [28]. This is further supported by a parallel GWAS meta-analysis effort in 19,840 samples where the G allele is similarly associated with increased triglycerides (P = 0.02) [29]. Using T2D case-control data from the DIAGRAM consortium [30], we found directionally-consistent, though only weak, associations with T2D-risk, most obviously at TFAP2B (P = 0.09; Table S9). An association between other non-HapMap TFAP2B variants and T2D has previously been reported in Japanese samples [21]. These T2D-associated variants show modest linkage disequilibrium to our WC associated SNP in UK samples (IVS1774_G/T and rs987237, r2 = 0.42; intron_1+2093_(A/C) and rs987237, r2 = 0.67). Thus, we see some evidence that the variants identified have anticipated effects on downstream phenotypes, although, as recently demonstrated for FTO (which has more marked effects on adiposity than the signals described here), analyses of this type have only limited power even in extremely large data sets [31].
###end p 54
###begin p 55
###xml 142 147 <span type="species:ncbi:9606">human</span>
In summary, by focusing on anthropometric measures of central obesity, we have identified three loci strongly implicated in the regulation of human adiposity and fat distribution. The extent of phenotypic variation explained by these variants is small. However, the variant or variants at each locus which are directly involved in influencing these traits are yet to be identified, and these may have more substantial effects. Even if this is not the case, effect size has very little bearing on the biological pertinence of these findings nor the potential impact of perturbing these pathways through therapeutic modification. Although determination of the influence of these signals on the development and maintenance of specific fat depots will require analyses that relate genetic variation to detailed imaging data in large numbers of subjects, the loci identified appear to highlight a variety of novel mechanisms involved in the regulation of adiposity. At this stage, it is unclear to what extent these same loci influence fat distribution in other ethnic groups, such as South Asians, in which patterns of fat distribution, and the relationships between fat distribution and metabolic disturbance, differ from those in Europeans. The data are consistent with a model whereby fat mass and distribution are determined through the concerted action of processes acting at the level of both the hypothalamus and peripheral fat depots.
###end p 55
###begin title 56
Methods
###end title 56
###begin title 57
Study Design Summary
###end title 57
###begin p 58
###xml 203 206 203 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Pischon1">[1]</xref>
###xml 600 608 600 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s003">Table S3</xref>
###xml 782 791 782 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-silico</italic>
###xml 868 875 868 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 1482 1490 1482 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000508-g001">Figure 1</xref>
Our study began with a genome-wide screen for discovery of loci potentially associated with two different anthropometric measures of central adiposity: waist circumference (WC) and waist-hip-ratio (WHR) [1]. For each of the traits we combined the summary statistics of 16 genome-wide association studies (GWAS) in meta-analyses with 38,580 (WC) and 37,670 (WHR) individuals, respectively (stage 1). These studies included nine population-based cohorts, four case cohorts (three for T2D and one for Hypertension), and three control cohorts (two originally paired with T2D and one with Breast Cancer) (Table S3). Following the discovery GWA meta-analysis, follow-up of our top association signals involved: (a) addition of data for markers of interest from studies with pre-existing "in-silico" GWA results (stage 2a; eight cohorts, maximum 13,830 individuals) and (b) "de novo" genotyping (stage 2b; 20 cohorts, maximum 56,859 individuals) giving a total of 70,689 (WC) or 61,612 (WHR) follow-up samples (collectively referred to as stage 2). In addition, genome wide signals for WC identified after stage 2 were confirmed using data with The Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium, whose meta-analysis included eight studies totaling 31,375 individuals. All samples included in these analyses were of European ancestry. We also undertook gender specific analysis of the stage 1 GWAS. An overview of the study design and results is given in Figure 1.
###end p 58
###begin title 59
Genome-Wide Association Meta-Analysis (Stage 1)
###end title 59
###begin title 60
Studies and phenotypes
###end title 60
###begin p 61
###xml 128 137 128 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s003">Tables S3</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s004">S4</xref>
###xml 229 241 <span type="species:ncbi:9606">participants</span>
All samples in the discovery cohorts were of European ancestry and detailed information on each of these studies is provided in Tables S3 and S4. Although we do not have specific age cut-offs for the individual cohorts the study participants are all adult (mean age between all cohorts = 55.7 years, range 31-70.3 years). All individuals provided informed consent and all studies were approved by local ethics committees.
###end p 61
###begin title 62
Choice of phenotypes
###end title 62
###begin p 63
###xml 185 193 185 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s001">Table S1</xref>
###xml 267 270 267 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Pischon1">[1]</xref>
###xml 320 328 320 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s001">Table S1</xref>
###xml 392 395 392 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Pischon1">[1]</xref>
###xml 537 538 537 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 589 597 565 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s001">Table S1</xref>
###xml 735 736 711 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 809 810 773 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 828 831 780 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Kamel1">[4]</xref>
The most appropriate adiposity measurements for assessing various fat compartments and the risk of adverse health outcomes is debated. Despite the close correlation between WC and BMI (Table S1), WC has been reported to have a BMI-independent impact on risk of death [1]. WHR is less strongly correlated to BMI than WC (Table S1) and is used as a more specific surrogate for fat distribution [1]. In our largest population based samples we see (as expected) that measures of central and overall adiposity are highly-correlated (BMI has r2approximately0.9 with WC and approximately0.6 WHR, Table S1). When compared to the gold standard of MRI measures of central adiposity, WC and WHR are equally well-correlated to central adiposity (r2approximately0.6, and 0.5, respectively) as are measures involving DXA (r2approximately0.6) [4].
###end p 63
###begin p 64
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Ross1">[32]</xref>
###xml 504 512 504 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s002">Table S2</xref>
WC and WHR were measured in the individual cohorts using standard protocols. Recently a multi-centre comparison of WC measurements at different sites showed that the measurement at different centres have no substantial influence on the association to various adverse health outcomes [32]. In line with this we detect little, if any, heterogeneity at our significant associations, which indicates that it is unlikely that any differences in measurement protocols are having a substantial effect on these (Table S2).
###end p 64
###begin title 65
Genotypes and imputation
###end title 65
###begin p 66
###xml 184 192 184 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s005">Table S5</xref>
###xml 1033 1037 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Li1">[33]</xref>
###xml 1052 1056 1052 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Marchini1">[34]</xref>
Operational details of each of the 16 GWAS (including genotyping platforms, quality control filters for individuals and SNPs, and imputation and data analysis methods) can be found in Table S5. In summary, stage 1 genotypes were derived using different genotyping platforms; Affymetrix 500 k, Illumina HumanHap 550, Illumina HumanCNV-370DUO, Illumina HumanHap300 Duo Infinium, or Illumina HumanHap 300. To obtain a marker set that was common to all studies, and to increase overall coverage of the whole genome, we imputed all SNPs reported in the CEU sample in HapMap Phase II using imputation algorithms, yielding a maximum of 2,573,738 million SNPs available for analysis in one or more studies. Imputations were performed after excluding samples and SNPs that did not meet the study-specific quality control criteria. Genotypes were imputed for SNPs not present in the genome-wide arrays or for those where genotyping had failed to meet the QC criteria. We used either of two different software packages for the imputation: MACH [33] () and IMPUTE [34] ().
###end p 66
###begin p 67
###xml 1383 1387 1365 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CETP</italic>
###xml 1409 1413 1391 1395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Willer1">[16]</xref>
Quality control (QC) criteria for SNPs to be included in the meta-analysis were minor allele frequency (MAF)>/=1% and for imputed SNPs good imputation quality, which was defined as proper_info>/=0.4 (for studies analysed with IMPUTE) or rsq-hat>/=0.3 (for studies analysed using MACH). The rsq_hat measure allows us to assess imputation accuracy for markers with many different allele frequencies. In comparison to filters based on the accuracy of individual genotype calls, it generally translates into a more stringent standard for rare SNPs and a more lenient standard for common SNPs. For intuition on how the measure performs consider the simple example of region where a particular SNP always occurs in a specific haplotype background. Further, assume that the SNP has a frequency of 10% and that the haplotype has a frequency of 20%. In this example, whenever we observed this particular haplotype we expect the SNP will be present approximately50% of the time so that >50% imputation accuracy cannot be achieved for this SNP. On the other hand, knowledge of the haplotype does provide useful information about the SNP, and the rsq_hat statistic takes a value of about 0.44 in this setting. There are examples of association between imputed SNPs with similar rsq_hat statistics and complex traits that have been confirmed in follow-up genotyping (e.g. the association between CETP and HDL cholesterol) [16].
###end p 67
###begin p 68
The studies analysed with IMPUTE typically used an additional filter to exclude imputed genotypes with a posterior probability <0.9 for IMPUTE. The proper_info measurement is interpretable as a value of x (between 0 and 1) means (approximately) that the amount of statistical information (about the parameter of interest in the model) at the imputed SNP is equivalent to perfect genotype data in a sample 100x% as big as the used sample size.
###end p 68
###begin p 69
###xml 215 223 215 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in press</italic>
###xml 225 229 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Huang1">[35]</xref>
###xml 230 234 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Pei1">[37]</xref>
###xml 328 335 328 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s011">Text S1</xref>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Willer1">[16]</xref>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Scott1">[38]</xref>
Empirical assessments show that genotype imputation using either MACH or IMPUTE provides an effective and accurate means of evaluating evidence for association at untyped markers [Li et al, Ann Rev Genom Hum Genet, in press; [35]-[37]. Furthermore, imputation is typically accurate even for strongly associated markers (see the Text S1[16],[38]).
###end p 69
###begin title 70
Study-specific stage 1 GWAS analysis
###end title 70
###begin p 71
###xml 295 296 295 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 685 686 685 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 890 894 890 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Marchini1">[34]</xref>
###xml 996 1000 996 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Li1">[33]</xref>
###xml 1352 1356 1352 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Scuteri1">[12]</xref>
###xml 1413 1417 1413 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Li1">[33]</xref>
###xml 1426 1430 1426 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Abecasis1">[39]</xref>
###xml 1443 1447 1443 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Marchini1">[34]</xref>
###xml 1092 1095 <span type="species:ncbi:9606">men</span>
###xml 1100 1105 <span type="species:ncbi:9606">women</span>
###xml 1206 1209 <span type="species:ncbi:9606">men</span>
###xml 1214 1219 <span type="species:ncbi:9606">women</span>
###xml 1244 1247 <span type="species:ncbi:9606">men</span>
###xml 1252 1257 <span type="species:ncbi:9606">women</span>
The GWAS analysis was performed by each study applying a standardized phenotype transformation to WC or WHR, respectively. Subjects were stratified by gender and the gender-specific rank of either the raw phenotype data or the residuals of a linear regression of the raw phenotype on age and age2 were inverse-normal transformed to yield normally distributed phenotypes. In case-control studies, cases and controls were analyzed separately. The additive genetic effect for each genotyped or imputed SNP was estimated using a linear regression model. For studies where the inverse-normal transformation was performed on raw phenotypes rather than residuals of the phenotype, age and age2 covariates were included in these tests. Some studies used association testing which takes genotype and imputation uncertainty into account using a missing data likelihood test implemented using SNPTEST [34] () or by using allele dosages as the independent variable in the linear regression model in MACH2QTL [33] (). To account for the clear gender dimorphism in these traits, analyses were performed in men and women separately, apart from the SardiNIA and deCODE studies for which, due to family relatedness between men and women, a combined analysis of men and women together was also performed, which accounted both for relatedness and gender in a single test [12]. For these GWAS analyses the software packages MACH2QTL [33], Merlin [39] and SNPTEST [34] were used.
###end p 71
###begin title 72
Meta-analysis of GWAS results
###end title 72
###begin p 73
###xml 263 284 263 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mixed-gender analysis</italic>
###xml 95 98 <span type="species:ncbi:9606">men</span>
###xml 103 108 <span type="species:ncbi:9606">women</span>
Results from the genome-wide analyses were meta-analysed by combining the separate results for men and women (or the combined gender results in the case of SardiNIA and deCODE) from each study together into one meta-analysis of overall effect for each phenotype (mixed-gender analysis).
###end p 73
###begin p 74
###xml 295 299 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Fisher1">[40]</xref>
###xml 358 362 355 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Whitlock1">[41]</xref>
###xml 708 712 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Normand1">[42]</xref>
Two methods were used in parallel for stage 1 meta-analyses. The first analysis approach we used was the weighted Z-method, which allows P-values and direction of effect to be combined independently of beta-estimates, allowing for incompatibility between phenotype units as in the Fisher method [40], but with improved power and precision over Fisher's test [41]. In this approach, study-specific P-values and direction of effect are converted into a signed Z-statistic. These Z-statistics are then summed with weights proportional to the square root of the sample size for each study. The other approach we used for our GWAS meta-analysis combines study-specific beta-estimates using the fixed effect model [42], using the inverse of the variance of the study-specific beta-estimates to weight the contribution of each study. Both meta-analysis methods are implemented in METAL (). Results from the two approaches were highly congruent in terms of P-values. The P-values we report here are those derived from the former meta-analysis method, as it was the first we performed and results using this method were used for the selection of the SNPs taken forward to follow-up. However, measures of effect size (as beta and standard error (SE)) can only be obtained from the latter.
###end p 74
###begin p 75
###xml 253 279 250 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">within-study GC correction</italic>
###xml 281 285 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Devlin1">[18]</xref>
Before performing either of these methods for a phenotype, within-study genomic control (GC) correction was applied to Z-statistics and to the variance of beta-estimates using lambda factors specific to each study calculated separately for each gender (within-study GC correction) [18]. The GC-correction approach is based on the lambda factor, which is computed as the median of all genome-wide observed test statistics (chi-square statistic) divided by the expected median of the test statistic under the null hypothesis of no association (making the assumption that the number of true associations is very small compared to the millions of tests performed). For each study-gender combination, the observed test statistic at each SNP was divided by the lambda factor to obtain GC corrected results.
###end p 75
###begin p 76
###xml 311 316 303 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC_WC</sub>
###xml 334 340 321 327 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC_WHR</sub>
###xml 449 470 436 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">overall GC correction</italic>
###xml 521 528 503 510 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC_1000</sub>
###xml 669 671 646 648 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC</sub>
###xml 696 700 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-deBakker1">[19]</xref>
###xml 792 802 764 774 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC_WC_1000</sub>
###xml 821 832 788 799 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GC_WHR_1000</sub>
After performing each meta-analysis, we again calculated a lambda factor based on the distribution of overall test statistics, i.e. from beta-estimates and SE based on the fixed effect method or on the Z-score from the weighted Z-score method. The overall lambda factors in the mixed-gender analysis were lambdaGC_WC = 1.09 and lambdaGC_WHR = 1.07 for the waist phenotypes. GC correction based on these overall lambda factors was then also applied (overall GC correction). We also found it informative to calculate lambdaGC_1000, which is an adjusted inflation factor for an equivalent study of 1,000 cases and 1,000 controls which can be calculated by rescaling lambdaGC as previously described [19]. The results for the mixed-gender analysis for these adjusted inflation factors were lambdaGC_WC_1000 = 1.003 and lambdaGC_WHR_1000 = 1.002 for the two waist phenotypes.
###end p 76
###begin p 77
###xml 55 56 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 132 140 129 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s002">Table S2</xref>
Finally, we computed (based on beta-estimates and SE) I2 statistics and Q-statistic P-values as measures of observed heterogeneity (Table S2).
###end p 77
###begin title 78
SNP selection for replication
###end title 78
###begin p 79
We aimed to select SNPs for replication that were enriched for signals of association with measures of central adiposity relative to overall adiposity or body size. To this end, we based our selection of markers for replication on evidence of association with WC or WHR (measures of central adiposity and fat distribution), while attempting to avoid associations that were primarily driven by associations with BMI (as an index of overall adiposity).
###end p 79
###begin p 80
###xml 45 47 43 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 303 304 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
First, we identified SNPs with a P-value</=10-5 in the preliminary analyses with at least one of the phenotypes. This set of SNPs was then separated into independent loci by taking the most significantly associated SNP and eliminating all SNPs that have a HapMap CEU pair-wise correlation coefficient (r2)>0.2 with that SNP, then proceeding to the next strongly associated SNP remaining. Seventy-six independent loci each represented by one main SNP met these criteria in our preliminary analysis.
###end p 80
###begin p 81
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Frayling1">[10]</xref>
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Loos1">[14]</xref>
###xml 106 110 106 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Willer1">[16]</xref>
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Thorleifsson1">[17]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Meyre1">[20]</xref>
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Weedon1">[43]</xref>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Gudbjartsson1">[46]</xref>
Previous experience with genome-wide association studies of anthropometric traits such as BMI [10], [14], [16]-[17],[20] and height [43]-[46] suggested that large numbers of additional samples would be required to establish association at levels of genome-wide significance. We focused our attention on 23 SNPs that showed strong association with at least one of the waist phenotypes, but with less significant evidence of association with BMI (p>0.01) and height (p>0.005), from previous analyses performed of stage 1 GWAS data within the GIANT consortia. These 23 SNPs thus had significantly stronger evidence of association with the waist phenotypes in our initial genome wide meta-analysis data than with BMI or height in previous meta-analyses involving comparable numbers of subjects.
###end p 81
###begin p 82
###xml 113 121 113 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s002">Table S2</xref>
We also added three SNPs that, despite not meeting all the P-value selection criteria, were near the borderline (Table S2) and for which biological credentials warranted selection:
###end p 82
###begin p 83
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGA2</italic>
###xml 119 124 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGA2</italic>
###xml 343 347 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Anand1">[47]</xref>
###xml 392 397 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HMGA2</italic>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Battista1">[48]</xref>
###xml 511 512 511 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 575 579 575 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Weedon1">[43]</xref>
###xml 580 584 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Lettre1">[45]</xref>
###xml 585 589 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Gudbjartsson1">[46]</xref>
###xml 248 252 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 257 263 <span type="species:ncbi:9606">humans</span>
###xml 274 278 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
rs7970350, which maps very near the HMGA2 (12q15) gene. In addition to being a strong biological candidate for height, HMGA2 is a strong biological candidate for obesity; rare mutations in this gene have previously been shown to alter body size in mice and humans. Hmga2-/- mice have a deficiency in fat tissue and resist diet-induced obesity [47]. Furthermore, the expression of a truncated HMGA2 gene induces gigantism associated with lipomatosis [48]. This marker is in perfect linkage disequilibrium (LD) (r2 = 1) with a previously described locus for height (rs1042725) [43],[45],[46]. Given the low correlation between waist-circumference and height, as well as the obvious candidacy for both height and obesity, we hypothesized that this loci might affect body shape (i.e. with independent effects on height and obesity).
###end p 83
###begin p 84
###xml 95 101 83 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCRTR2</italic>
###xml 547 551 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Hara1">[49]</xref>
###xml 552 556 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Funato1">[51]</xref>
rs11970116, which maps approximately90 kb upstream of the hypocretin (orexin) receptor 2 gene, HCRTR2 (6p11-q11). Orexins and their receptors are good candidate genes for adiposity as the orexin pathway has been implicated in the control of energy homeostasis as well as in narcolepsy and sleep patterns (ref 21). It has also been reported that hypothalamic orexin promotes appetite and that HCRTR2 signaling confers resistance to diet-induced features of the metabolic syndrome through negative energy homeostasis and improved leptin sensitivity [49]-[51].
###end p 84
###begin p 85
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 208 209 208 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 289 295 277 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 345 353 333 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000508-g002">Figure 2</xref>
rs987237, which maps to intron 3 of the TFAP2B (6p12) gene to add a second SNP in the vicinity of this locus in addition to rs4715215 that was already selected as one of our 23 SNPs for follow-up (pair wise r2 = 0.236; D' = 1). While rs4715215 is located approximately145 kb downstream of TFAP2B, rs987237 is located within the gene transcript (Figure 2).
###end p 85
###begin p 86
###xml 353 362 353 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s002">Tables S2</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s006">S6</xref>
Thus, including both the 23 SNPs meeting our filtering criteria and the three additional variants, we targeted a total of 26 independent SNPs for replication in additional samples. As there were some SNPs for which the stage 1 association met the selection criteria for more than one of the waist phenotypes, there were 30 analyses to be performed (see Tables S2 and S6).
###end p 86
###begin title 87
Follow-Up in Independent GIANT Consortium Samples (GIANT Stage 2)
###end title 87
###begin title 88
Studies and phenotypes
###end title 88
###begin p 89
###xml 130 139 130 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-silico</italic>
###xml 167 174 167 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 650 659 650 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s003">Tables S3</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s004">S4</xref>
###xml 665 667 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s005">S5</xref>
###xml 555 567 <span type="species:ncbi:9606">participants</span>
For our own Stage 2 analysis, we sought follow-up samples from two independent routes: we included studies with pre-existing GWAS in-silico data (stage 2a) as well as de novo genotyping (stage 2b) comprising 27 cohorts for WC and 21 cohorts for WHR. Among these stage 2 studies, 18 studies were also able to provide data on BMI, weight, and height. All individuals included in stage 2 studies were of European ancestry and provided informed consent. All studies were approved by the local ethics committees. Study-specific information on study design and participants, phenotype means, and experimental detail for all stage 2 studies are included in Tables S3, S4, S5.
###end p 89
###begin title 90
Additional phenotypes
###end title 90
###begin p 91
In addition to data on the waist phenotypes (WC and WHR) and other relevant anthropometric traits (BMI, weight, and height), we also had some cohorts from both stage 1 and stage 2 which were able to provide bioimpedance data (BIA) and/or Dual energy X-ray absorptiometry (DXA). In stage 1, three studies were informative for BIA (maximum N = 9,852), and two (maximum N = 2,308) had data on DXA. In stage 2, a total of seven cohorts had BIA (maximum N = 20,934) and six had DXA data (maximum N = 12,954). Thus, the total sample size for BIA and DXA was 30,786 or 15,262, respectively.
###end p 91
###begin title 92
Genotypes
###end title 92
###begin p 93
###xml 190 197 190 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
Genotypes were obtained from stage 2a studies, in which each SNP was either directly genotyped or imputed from genome-wide data using the CEU HapMap reference panel, and from stage 2b using de novo genotyping undertaken using a variety of platforms including Biotrove, Centaurus, KASPar, Sequenom, Sequenom iPLEX, and TaqMan-based assays.
###end p 93
###begin p 94
###xml 153 161 153 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s005">Table S5</xref>
###xml 315 323 315 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s006">Table S6</xref>
Genotyping platforms, calling algorithms, quality control before imputation, imputation methods, and analysis software used were all study-specific (see Table S5 for detailed information on each study). The explicit number of follow-up SNPs genotyped in each study and whether a proxy SNP was used is summarized in Table S6.
###end p 94
###begin title 95
Study-specific stage 2 association analyses
###end title 95
###begin p 96
###xml 168 169 168 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 231 234 <span type="species:ncbi:9606">men</span>
###xml 239 244 <span type="species:ncbi:9606">women</span>
To analyze the two waist phenotypes in the stage 2 studies, we used the same analysis model as in stage 1 (inverse-normal transformed WC or WHR adjusted for age and age2 analyzed in a linear regression, all performed separately in men and women).
###end p 96
###begin p 97
###xml 55 58 <span type="species:ncbi:9606">men</span>
###xml 63 68 <span type="species:ncbi:9606">women</span>
Additional analyses were performed - all separately in men and women and all using an additive genetic effect model - to obtain:
###end p 97
###begin p 98
###xml 126 127 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
waist phenotype association independent from overall obesity (using inverse-normal transformed WC or WHR adjusted for age, age2 and BMI)
###end p 98
###begin p 99
###xml 101 102 101 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
raw estimates of effect sizes for WC and WHR (using untransformed WC or WHR, adjusted for age and age2)
###end p 99
###begin p 100
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
raw estimates of BMI effect sizes (using untransformed BMI adjusted for age and age2)
###end p 100
###begin p 101
###xml 152 153 152 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
association estimates in studies with % fat phenotypes (using untransformed % total fat BIA, % total fat DXA, % central fat DXA adjusted for age and age2).
###end p 101
###begin title 102
GIANT Stage 2 meta-analyses
###end title 102
###begin p 103
We performed a meta-analysis for the phenotypes of primary interest (WC and WHR) of all stage 2 studies using the same methods as in stage 1 (pooled P-values using the weighted Z-score method; pooled beta- and SE estimates using the fixed effect method; as well as heterogeneity statistics).
###end p 103
###begin title 104
Meta-analysis of all GIANT data (stage 1+stage 2)
###end title 104
###begin p 105
We combined GIANT stage 1 and stage 2 samples to derive a combined meta-analysis of all studies, performed in the same manner as in stage 1 and stage 2 analyses. Results from stage 1 and stage 2 studies were combined into one N-way meta-analysis.
###end p 105
###begin p 106
###xml 112 118 112 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TFAP2B</italic>
###xml 276 284 276 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s002">Table S2</xref>
Five of the 26 loci that were selected for follow up show nominal evidence of association with both WC and WHR (TFAP2B (rs987237) was one of these). However, for none of these loci did the association with WHR reach genome-wide significance in the overall, combined analysis (Table S2).
###end p 106
###begin title 107
GIANT Gender-specific meta-analysis (stage 1, stage 2, and stage 1+2)
###end title 107
###begin p 108
###xml 113 116 113 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000508-Zillikens1">[7]</xref>
###xml 188 191 <span type="species:ncbi:9606">men</span>
###xml 196 201 <span type="species:ncbi:9606">women</span>
###xml 364 367 <span type="species:ncbi:9606">men</span>
###xml 372 377 <span type="species:ncbi:9606">women</span>
###xml 441 444 <span type="species:ncbi:9606">men</span>
###xml 486 491 <span type="species:ncbi:9606">women</span>
The waist phenotypes exhibit strong gender-differences and evidence for some genetic effects on fat distribution [7], so we performed additional meta-analyses of our stage 1 GWAS in which men and women were analyzed separately. We also tested whether the effect estimate resulting from the gender-specific fixed effect meta-analysis differed significantly between men and women by applying a t-test comparing beta-effect and SE estimates in men with the beta-effect and SE estimates in women. The gender-specific meta-analyses were performed on stage 1, stage 2, and combined stage 1+2 data.
###end p 108
###begin title 109
###xml 55 64 55 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Silico</italic>
Additional Replication through Further Follow-Up Using In Silico Results from the CHARGE Consortium
###end title 109
###begin p 110
###xml 259 266 259 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000508-t001">Table 1</xref>
Further, our genome wide signals for WC identified after stage 2 were confirmed using data from the "Cohorts for Heart and Aging Research in Genomic Epidemiology" (CHARGE) consortium, which members had performed a GWAS meta-analysis of 31,375 samples for WC (Table 1).
###end p 110
###begin title 111
Studies, phenotypes, and genotypes
###end title 111
###begin p 112
The CHARGE consortium consisted of 31,375 individuals from 8 studies informative for WC, though two studies overlapped with our stage 2a studies (the Erasmus Rucphen Family Study (ERF) and the Rotterdam Study (ERGO), (up to 6,702 individuals) which were included in both CHARGE and stage 2 data, but which are counted only once in the overall meta-analysis.
###end p 112
###begin title 113
Meta-analysis of stage 1+2 results with CHARGE data
###end title 113
###begin p 114
###xml 128 136 128 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000508-g001">Figure 1</xref>
We combined the association results for WC from the GIANT and CHARGE samples to derive a combined meta-analysis of all studies (Figure 1). This analysis was performed using the METAL software for pooling of the P-values based on the weighted Z-score method, using the P-values calculated in our stage 1+2 meta-analysis (excluding ERF and ERGO) along with the P-values from CHARGE. For a more detailed description of the CHARGE consortium studies and their analysis methods, ([Fox et al. submitted to PLOS Genetics (2008)] and []).
###end p 114
###begin p 115
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MSRA</italic>
###xml 562 563 562 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
For the MSRA locus, genotypes for rs7826222 were only available for a subset of the CHARGE samples (N = 8,097). This is due to the fact that this SNP has been renamed to rs545854 in NCBI build 36 and was consequently one of the SNPs omitted from HapMap release 22 and therefore is not present in build 36 imputations based on that release of HapMap. Nonetheless, the effect of rs7826222 in CHARGE was directionally-consistent (P = 0.28), and CHARGE data available in larger sample size (N = 31,372) for two moderately-good proxies (rs1876511 and rs613080, both r2 = 0.76 with rs7826222/rs545854) and both show some support (both had directionally-consistent effect-sizes and P = 0.078) with the other findings.
###end p 115
###begin title 116
Supporting Information
###end title 116
###begin p 117
###xml 56 59 <span type="species:ncbi:9606">men</span>
###xml 64 69 <span type="species:ncbi:9606">women</span>
Phenotypic correlation between anthropometric values in men and women.
###end p 117
###begin p 118
(0.02 MB XLS)
###end p 118
###begin p 119
Click here for additional data file.
###end p 119
###begin p 120
The loci that were followed up in GIANT Stage 2.
###end p 120
###begin p 121
(0.04 MB XLS)
###end p 121
###begin p 122
Click here for additional data file.
###end p 122
###begin p 123
Description of samples included in the GWA meta-analysis (Stage 1) and follow-up studies (stage 2).
###end p 123
###begin p 124
(0.03 MB XLS)
###end p 124
###begin p 125
Click here for additional data file.
###end p 125
###begin p 126
Descriptive characteristics of genome-wide association study cohorts (Stage 1) and follow-up study cohorts (Stage 2).
###end p 126
###begin p 127
(0.04 MB XLS)
###end p 127
###begin p 128
Click here for additional data file.
###end p 128
###begin p 129
Information on genotyping methods, quality control of SNPs, imputation, and statistical analysis for Stage 1 and 2 study cohorts.
###end p 129
###begin p 130
(0.04 MB XLS)
###end p 130
###begin p 131
Click here for additional data file.
###end p 131
###begin p 132
Lead markers and proxies used in stage 2 replication.
###end p 132
###begin p 133
(0.03 MB XLS)
###end p 133
###begin p 134
Click here for additional data file.
###end p 134
###begin p 135
Association analysis of fat phenotypes using raw estimates for the significant loci.
###end p 135
###begin p 136
(0.02 MB XLS)
###end p 136
###begin p 137
Click here for additional data file.
###end p 137
###begin p 138
The effect of the genome wide significant adiposity loci on lipids within ENGAGE cohorts.
###end p 138
###begin p 139
(0.02 MB XLS)
###end p 139
###begin p 140
Click here for additional data file.
###end p 140
###begin p 141
The effect of the genome wide significant adiposity loci on type 2 diabetes risk.
###end p 141
###begin p 142
(0.02 MB XLS)
###end p 142
###begin p 143
Click here for additional data file.
###end p 143
###begin p 144
The association results for waist-circumference and waist-hip-ratio to the recently reported 17 BMI loci.
###end p 144
###begin p 145
(0.03 MB XLS)
###end p 145
###begin p 146
Click here for additional data file.
###end p 146
###begin p 147
Supporting text and acknowledgments.
###end p 147
###begin p 148
(0.16 MB DOC)
###end p 148
###begin p 149
Click here for additional data file.
###end p 149
###begin p 150
###xml 326 333 326 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000508.s011">Text S1</xref>
The authors would like to thank the many colleagues who contributed to collection and phenotypic characterization of the clinical samples, as well as genotyping and analysis of the GWA data. They would also like to acknowledge those who agreed to participate in these studies. Full details of acknowledgements are provided in Text S1.
###end p 150
###begin title 151
References
###end title 151
###begin article-title 152
General and abdominal adiposity and risk of death in Europe.
###end article-title 152
###begin article-title 153
###xml 56 68 <span type="species:ncbi:9606">participants</span>
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study.
###end article-title 153
###begin article-title 154
###xml 27 30 <span type="species:ncbi:9606">men</span>
Adiposity and mortality in men.
###end article-title 154
###begin article-title 155
###xml 79 82 <span type="species:ncbi:9606">men</span>
###xml 87 92 <span type="species:ncbi:9606">women</span>
Usefulness of anthropometry and DXA in predicting intra-abdominal fat in obese men and women.
###end article-title 155
###begin article-title 156
Sex differences in heritability of BMI: a comparative study of results from twin studies in eight countries.
###end article-title 156
###begin article-title 157
###xml 82 87 <span type="species:ncbi:9606">women</span>
Genetic and behavioral determinants of waist-hip ratio and waist circumference in women twins.
###end article-title 157
###begin article-title 158
Sex-specific genetic effects influence variation in body composition.
###end article-title 158
###begin article-title 159
Acquired and inherited lipodystrophies.
###end article-title 159
###begin article-title 160
Variation in FTO contributes to childhood obesity and severe adult obesity.
###end article-title 160
###begin article-title 161
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity.
###end article-title 161
###begin article-title 162
The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase.
###end article-title 162
###begin article-title 163
Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits.
###end article-title 163
###begin article-title 164
Common genetic variation near MC4R is associated with waist circumference and insulin resistance.
###end article-title 164
###begin article-title 165
Common variants near MC4R are associated with fat mass, weight and risk of obesity.
###end article-title 165
###begin article-title 166
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human obesity: a heritable neurobehavioral disorder that is highly sensitive to environmental conditions.
###end article-title 166
###begin article-title 167
Six new loci associated with body mass index highlight a neuronal influence on body weight regulation.
###end article-title 167
###begin article-title 168
Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity.
###end article-title 168
###begin article-title 169
Genomic control for association studies.
###end article-title 169
###begin article-title 170
Practical aspects of imputation-driven meta-analysis of genome-wide association studies.
###end article-title 170
###begin article-title 171
Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations.
###end article-title 171
###begin article-title 172
Genetic variations in the gene encoding TFAP2B are associated with type 2 diabetes mellitus.
###end article-title 172
###begin article-title 173
The transcription factor AP-2beta causes cell enlargement and insulin resistance in 3T3-L1 adipocytes.
###end article-title 173
###begin article-title 174
Transcription factor activating enhancer-binding protein-2beta. A negative regulator of adiponectin gene expression.
###end article-title 174
###begin article-title 175
Intronic polymorphisms within TFAP2B regulate transcriptional activity and affect adipocytokine gene expression in differentiated adipocytes.
###end article-title 175
###begin article-title 176
###xml 44 49 <span type="species:ncbi:9606">human</span>
Adipocyte triglyceride lipase expression in human obesity.
###end article-title 176
###begin article-title 177
Insulin-stimulated exocytosis of GLUT4 is enhanced by IRAP and its partner tankyrase.
###end article-title 177
###begin article-title 178
Tankyrase is a golgi-associated mitogen-activated protein kinase substrate that interacts with IRAP in GLUT4 vesicles.
###end article-title 178
###begin article-title 179
Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts.
###end article-title 179
###begin article-title 180
Common variants at 30 loci contribute to polygenic dyslipidemia.
###end article-title 180
###begin article-title 181
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes.
###end article-title 181
###begin article-title 182
Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI.
###end article-title 182
###begin article-title 183
Does the relationship between waist circumference, morbidity and mortality depend on measurement protocol for waist circumference?
###end article-title 183
###begin article-title 184
Mach 1.0: Rapid Haplotype Reconstruction and Missing Genotype Inference.
###end article-title 184
###begin article-title 185
A new multipoint method for genome-wide association studies by imputation of genotypes.
###end article-title 185
###begin article-title 186
###xml 46 51 <span type="species:ncbi:9606">human</span>
Genotype-imputation accuracy across worldwide human populations.
###end article-title 186
###begin article-title 187
A comprehensive evaluation of SNP genotype imputation.
###end article-title 187
###begin article-title 188
Analyses and comparison of accuracy of different genotype imputation methods.
###end article-title 188
###begin article-title 189
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants.
###end article-title 189
###begin article-title 190
Merlin-rapid analysis of dense genetic maps using sparse gene flow trees.
###end article-title 190
###begin article-title 191
The Genetical Interpretation of Statistics of the Third Degree in the Study of Quantitative Inheritance.
###end article-title 191
###begin article-title 192
Combining probability from independent tests: the weighted Z-method is superior to Fisher's approach.
###end article-title 192
###begin article-title 193
Meta-analysis: formulating, evaluating, combining, and reporting.
###end article-title 193
###begin article-title 194
Genome-wide association analysis identifies 20 loci that influence adult height.
###end article-title 194
###begin article-title 195
A common variant of HMGA2 is associated with adult and childhood height in the general population.
###end article-title 195
###begin article-title 196
###xml 88 93 <span type="species:ncbi:9606">human</span>
Identification of ten loci associated with height highlights new biological pathways in human growth.
###end article-title 196
###begin article-title 197
###xml 52 57 <span type="species:ncbi:9606">human</span>
Many sequence variants affecting diversity of adult human height.
###end article-title 197
###begin article-title 198
In vivo modulation of Hmgic reduces obesity.
###end article-title 198
###begin article-title 199
The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis.
###end article-title 199
###begin article-title 200
###xml 56 60 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 89 93 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions.
###end article-title 200
###begin article-title 201
Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.
###end article-title 201
###begin article-title 202
Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity.
###end article-title 202
###begin p 203
The authors from Decode Genetics Inc. own stocks and stock options in the company. VM, NL, KS and DMW are full-time employees of GlaxoSmithKline, a pharmaceutical company. The other authors have no competing interests to declare.
###end p 203
###begin p 204
Major project or personal funding for the work described in this paper comes from the Academy of Finland (104781, 124243), ADA Smith Family Foundation Pinnacle Program, the American Diabetes Association, Arthritis Research Campaign, AstraZeneca AB, The Barts and The London Charity, Biocentrum Helsinki, Biotechnology and Biological Sciences Research Council (UK), British Heart Foundation, Camstrad, Cancer Research UK, CIDR (NIH Contract Number N01-HG-65403), Diabetes UK, the European Commission (Framework VI: LSHG-CT-2004-518153 [EURODIA]; LSHG-CT-2004-512066 [MolPAGE]; LSHM-CT-2006-037197; LSHM-CT-2003-503041; QL46-CT-2002-02629 [GENOMOS]; LSHM-CT-2007-037273; Framework VII: HEALTH-F4-2007- 201413 [ENGAGE]), the Faculty of Biology and Medicine of Lausanne, Switzerland, the Swiss National Science Foundation (Grant 33CSCO-122661, the Finnish Heart Association, the Finnish Cultural Foundation, Folkhalsan Research Foundation, the German National Genome Research Net, GlaxoSmithKline, the Sigrid Juselius Foundation, the Karolinska Institute, Kings College London, the Knut and Alice Wallenberg Foundation, the Medical Research Council UK (G0000934, G0000649, G0601261, G0500539, G9521010D, G0600705), MedStar Research Institute, Munich Center of Health Sciences, National Institutes of Health (US: intramural programs (1Z01-HG000024), National Institute on Aging; NHLBI (HL087679 [STAMPEED], HL084729), NIDDK (DK062370; DK072193; DK075787; DK079466; DK080145; DK067288; DK07191), NHGRI (HG02651), the Netherlands Organization for Scientific Research, the Netherlands Center of Medical Systems Biology, the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) (050-060-810), Novartis, Peninsula Medical School, Scottish Executive Chief Scientist's Office, Stockholm County Council (560183), Support for Science Funding (UK); Swedish Heart-Lung Foundation, the Swedish Medical Research Council (8691), UK National Institute of Health Research, UK Department of Health Policy Research Programme, University of Oxford, Vandervell Foundation and Wellcome Trust (068545/Z/02, GR072960, GR076113, GR069224, 086596/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 204

